Last reviewed · How we verify

Intravenous ibuprofen

Biomendi S.A.U. · FDA-approved active Small molecule

Intravenous ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.

Intravenous ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain. Used for Fever reduction in hospitalized patients, Acute pain management in hospitalized patients.

At a glance

Generic nameIntravenous ibuprofen
Also known asIV ibuprofen, Caldolor, Pedea i.v., ibuprofen, Intravenous Acetaminophen
SponsorBiomendi S.A.U.
Drug classNonsteroidal anti-inflammatory drug (NSAID)
TargetCOX-1 and COX-2
ModalitySmall molecule
Therapeutic areaPain Management, Inflammation
PhaseFDA-approved

Mechanism of action

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that blocks both COX-1 and COX-2 enzymes, which are responsible for producing prostaglandins that mediate inflammation, pain, and fever. The intravenous formulation provides rapid systemic delivery for acute pain and fever management in hospitalized patients who cannot take oral medication.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results